T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Hecla Mining
HL
$11.9B
| $39.5M | ﹤0.01% |
2,056,219
-503,251
| -20% | -$7.69M |
|
877
ADMA Biologics
ADMA
$2.11B
| $39.4M | ﹤0.01% |
2,160,559
+4,897
| +0.2% | +$82.5K |
|
|
TERN
878
DELISTED
Terns Pharmaceuticals
TERN
| $39.4M | ﹤0.01% |
974,312
+880,139
| +935% | +$20.3M |
|
879
Ollie's Bargain Outlet
OLLI
$4.7B
| $39.3M | ﹤0.01% |
358,734
-98,336
| -22% | -$11.9M |
|
880
Hershey
HSY
$37.4B
| $39.2M | ﹤0.01% |
215,612
-439
| -0.2% | -$80.3K |
|
881
NetApp
NTAP
$40.2B
| $38.9M | ﹤0.01% |
363,259
-46,208
| -11% | -$5.28M |
|
882
Xenon Pharmaceuticals
XENE
$6.21B
| $38.6M | ﹤0.01% |
862,300
+820,608
| +1,968% | +$34.5M |
|
883
Coca-Cola Consolidated
COKE
$12.7B
| $38.3M | ﹤0.01% |
249,986
-241
| -0.1% | -$35.4K |
|
884
HDFC Bank
HDB
$119B
| $38.3M | ﹤0.01% |
1,047,088
-78,867
| -7% | -$2.84M |
|
885
Primerica
PRI
$9.62B
| $38.2M | ﹤0.01% |
147,811
+1,291
| +0.9% | +$337K |
|
886
Nutanix
NTNX
$18.4B
| $38.1M | ﹤0.01% |
736,276
-524,084
| -42% | -$32M |
|
|
PPL
887
PPL Corp
PPL
$26.8B
| $38M | ﹤0.01% |
1,085,804
-9,182
| -0.8% | -$331K |
|
888
Palomar
PLMR
$3.37B
| $38M | ﹤0.01% |
281,603
+722
| +0.3% | +$88.1K |
|
889
Dynatrace
DT
$14.7B
| $37.8M | ﹤0.01% |
872,575
-8,457,003
| -91% | -$394M |
|
890
Cincinnati Financial
CINF
$26.5B
| $37.6M | ﹤0.01% |
230,381
+1,241
| +0.5% | +$201K |
|
891
Omnicom Group
OMC
$24.2B
| $37.6M | ﹤0.01% |
465,884
+140,670
| +43% | +$10.7M |
|
892
Stride
LRN
$3.48B
| $37.6M | ﹤0.01% |
578,903
-387,699
| -40% | -$35.2M |
|
893
Performance Food Group
PFGC
$16.4B
| $37.6M | ﹤0.01% |
417,777
+1,407
| +0.3% | +$136K |
|
894
JB Hunt Transport Services
JBHT
$26.5B
| $37.4M | ﹤0.01% |
192,190
+77,485
| +68% | +$13.3M |
|
895
Q2 Holdings
QTWO
$4.13B
| $37.4M | ﹤0.01% |
517,595
-35,763
| -6% | -$2.46M |
|
896
Group 1 Automotive
GPI
$3.14B
| $37.2M | ﹤0.01% |
94,676
+580
| +0.6% | +$238K |
|
897
The Mosaic Company
MOS
$6.92B
| $37.2M | ﹤0.01% |
1,543,885
-58,108
| -4% | -$1.56M |
|
898
Citizens Financial Group
CFG
$31.2B
| $37.2M | ﹤0.01% |
636,695
+548
| +0.1% | +$29.4K |
|
|
NAVN
899
Navan Inc
NAVN
$7.56B
| $37.1M | ﹤0.01% |
+2,175,013
| New | +$34.6M |
|
900
BJs Wholesale Club
BJ
$11.9B
| $37.1M | ﹤0.01% |
412,205
+30,179
| +8% | +$2.77M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.